On April 28, 2025, the Seventh Membership Congress of the Chinese Association of Young Scientists and Technologists (CAYST) convened in Beijing, attended by over 300 delegates. The congress reviewed and approved the association's work report, the revised CAYST Charter, and elected a new Council and Supervisory Board. Following this, the first plenary meetings of the Seventh Council and the First Supervisory Board were held, where the President, Vice Presidents, Secretary-General, and other leadership positions were elected. Professor Lin Haotian, Director of the Zhongshan Ophthalmic Center (ZOC) at Sun Yat-sen University (SYSU) and Director of the State Key Laboratory of Ophthalmology, was elected Vice President of the Seventh Council of CAYST.

Profile of Professor Lin Haotian:

• Positions: Director of Zhongshan Ophthalmic Center, SYSU; Director of the State Key Laboratory of Ophthalmology; Head of the Department of Genetics and Biomedical Informatics, Zhongshan Medical School, SYSU.
• Academic Titles: Senior Professor; Chief Physician (Class I); Senior Researcher; Doctoral Supervisor in both Ophthalmology and Biomedical Engineering (Dual-discipline).
• Major Honors & Appointments:
  • National High-Level Talent
  • Outstanding Young and Middle-Aged Expert with significant Contributions (National Health Commission)
  • Recipient of China Youth May Fourth Medal
  • Standing Committee Member, All-China Youth Federation
  • Chief Scientist, National Key R&D Program Project (Awarded "Excellent Completion")
  • Director, Asia Office, Afro-Asian Council of Ophthalmology (AACO)
  • AI Medical Device Evaluation Expert, National Medical Products Administration (NMPA)
  • Vice Chair, Professional Committee of Smart Medical, Chinese Association for Artificial Intelligence (CAAI)
  • Vice President, Ambulatory Medical Economics and Administration Branch, China Health Economics Association
• Academic Achievements:
  • Published over 200 SCI-indexed papers as first or corresponding author in top international journals including Nature, Nature Medicine, Science, The Lancet, and The BMJ.
  • Edited 5 monographs.
  • Led the development of 8 application standards and specifications.
  • Holds 47 domestic and international patents and 12 software copyrights, with 5 technologies successfully transferred and implemented.
• Major Awards: First Prize of Wu Wenyuan AI Science and Technology Award (2021); Inaugural Zhong Nanshan Youth Scientific and Technological Innovation Award.
• Key Research Contributions:
  • Pioneered an AI-based screening and diagnosis system for blinding eye diseases, driving global advances in intelligent medicine.
  • Developed an ophthalmic surgical navigation system and robot, significantly enhancing surgical predictability, precision, and stability.
  • Established a three-tiered platform for the application of intelligent diagnosis and treatment technologies, revolutionizing the prevention model and efficacy in combating blinding eye diseases.
  • These technological achievements have been widely adopted across representative medical institutions at all levels in China and within countries and regions participating in the Belt and Road Initiative, benefiting millions of residents and patients.